<qa>  What is the name of the study that suggests Rituximab and combination chemotherapy will provideThe investigators hypothesize that Rituximab together with combination chemotherapy, followed by Rituximab maintenance therapy, will provide better disease control with improved response rates and overall survival in patients with previously untreated Mantle Cell Lymphoma MCL. 